END-ZIT
-
sulfur lotion, augmented
ABBE Laboratories, Inc.
----------
END-ZIT® ACNE CONTROL DRYING LOTION
Intended for use on blemishes only. This advanced formulation is designed to dry and aid in elimination of pimples. It is make-up quality for excellent coverage of the blemish. It is unbelievably effective, clinically tested, dermatologist approved and recommended.
DIRECTIONS: Shake bottle well before each use. Apply directly to blemish only, using applicator. Wait a few moments until slightly dry. Pat with fingertip or clean cotton swab to blend color to skin. Make-up may be applied if desired. Should remain on skin all day. Re-apply at night to clean skin to remain on skin overnight.
NOTE: PERSONS WITH KNOWN SENSITIVITY TO SULFUR SHOULD AVOID USE OF THIS PRODUCT.
KEEP FROM EYES.
DRUG FACTS
ACTIVE INGREDENT ............ SULFUR 5%
PURPOSE ............. ACNE TREATMENT
WARNINGS:
• For external use only.
• Using other topical acne medications at the same time or immediately following use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor.
• Do not get into eyes. If excessive skin irritation deve lops or increases, discontinue use and consult a doctor.
• Keep out of reach of children.
OTHER INGREDIENTS: Isopropyl Alcohol, Water, Zinc Oxide, Propylene Glycol, Camphor, Talc, Sodium Laureth Sulfate, Titanium Dioxide, Diazolidinyl Urea, Methylparaben, Propylparaben. May contain Iron Oxides.
NDC #'s
Brown 68605-2004-2
Medium/Dark 68605-2005-2
DIRECTIONS: SHAKE BOTTLE WELL.
APPLY TWICE DAILY DIRECTLY TO
ACNE BREAKOUT. ALLOW TO DRY
FOR 10 SECONDS. PAT TO BLEND.
APPLY MAKE-UP IF DESIRED.
ACTIVE INGREDIENT: SULFUR 5%.
WARNINGS:
AVOID IF ALLERGIC TO SULFUR
AVOID CONTACT WITH EYES
FOR EXTERNAL USE ONLY
KEEP FROM CHILDREN
Manufactured by ABBE Laboratories, Inc.
Farmingdale, NY 11735
Made in the U.S.A.
END-ZIT®
ACNE CONTROL
DRYING LOTION
ABBE
0.62 OZ. (17.57 g)
END-ZIT
sulfur
lotion, augmented |
|
|
|
|
|
END-ZIT
sulfur
lotion, augmented |
|
|
|
|
|
Revised: 03/2011ABBE Laboratories, Inc.